Christina Long
Physician Assistant · Amherst, NYNPI 1326122250
Payments from drug & device makers
Across 447 payments — averaging $26.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$2K
- GSK$1K
- Sanofi$1K
- AstraZeneca$1K
- Amgen$537
- plus $3K from 28 others
What the payments were for
- Consulting fees$2,37520%
- Travel & lodging$5014%
- Food & beverage$8,89875%
- Education$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 11 | $3,045 |
| Regeneron Healthcare Solutions, Inc. | 75 | $1,707 |
| GSK | 93 | $1,432 |
| Sanofi | 48 | $1,146 |
| AstraZeneca | 49 | $1,045 |
| Amgen(2 entities) | 26 | $537 |
| Pfizer | 21 | $473 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $434 |
| CSL Behring | 15 | $346 |
| Kaleo, Inc. | 12 | $205 |
| Biocryst US Sales Co., LLC | 11 | $204 |
| Novartis | 16 | $188 |
| Grifols USA, LLC | 3 | $117 |
| Alk-abello, Inc | 5 | $106 |
| Incyte Corporation | 4 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $93 |
| Pharming Healthcare, Inc. | 4 | $92 |
| Blueprint Medicines Corporation | 3 | $83 |
| Optinose US, Inc. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Galderma Laboratories, L.p. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Phadia US Inc. | 2 | $41 |
| USWM, LLC | 1 | $26 |
| Octapharma USA, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
| Merck | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Covis Pharma GmbH | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| W. L. Gore & Associates, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,833 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 90 | $348,961 |
| Dupixent SyringeDupilumab | 68 | $273,020 |
| NucalaMepolizumab | 44 | $192,395 |
| XolairOmalizumab | 64 | $175,892 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 103 | $81,173 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 209 | $43,582 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $28,104 |
| Spiriva RespimatTiotropium Bromide | 21 | $19,495 |
| SymbicortBudesonide/Formoterol Fumarate | 58 | $19,433 |
| Advair HfaFluticasone Propion/Salmeterol | 32 | $19,277 |
| Arnuity ElliptaFluticasone Furoate | 44 | $17,882 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 44 | $10,907 |
| Epinephrine | 35 | $9,017 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $7,941 |
| DuleraMometasone/Formoterol | 19 | $7,880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,432 | $319,555239 claims |
| AstraZenecaSymbicort, Pulmicort Flexhaler | $1,045 | $26,28280 claims |
| Boehringer IngelheimSpiriva Respimat | $20 | $19,49521 claims |
| MerckDulera, Asmanex | $22 | $11,55437 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $51 | $7,94120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Amherst
- Michael AsbachAmherst$962K
- Madeline SliszAmherst$101K
- Rachel AllenAmherst$54K
- Lauren JendraszekAmherst$40K
- Delaney FragaleAmherst$33K
- Henry YuBronx$1M
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.